Status:
ACTIVE_NOT_RECRUITING
Effects of a Novel Neurofeedback Protocol on ADHD Subcomponents
Lead Sponsor:
University Hospital, Geneva
Collaborating Sponsors:
University of Geneva, Switzerland
Conditions:
Attention Deficit Disorder With Hyperactivity
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
Mounting evidence suggests that closed-loop brain-training, commonly known as neurofeedback (NFB), may represent a new therapeutic opportunity for patients with Attentional Deficit/Hyperactivity Disor...
Eligibility Criteria
Inclusion
- Clinical diagnosis of ADHD
- Currently stabilized (euthymic)
- General good health
- Normal or corrected-to normal visual acuity
Exclusion
- Mood Disorders
- PTSD
- Borderline Personality Disorder
- Substance Use Disorder
- Structural Brain Abnormalities
- Cerebrovascular Disease
- Epilepsy
- Stroke
- Head Trauma
- Cardiovascular Disease
- Renal Failure
- Hepatic Dysfunction
- Impaired visual acuity
Key Trial Info
Start Date :
November 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2026
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04408521
Start Date
November 2 2020
End Date
April 1 2026
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals of Geneva
Geneva, Switzerland, 1201